Louise A. Quenneville

Human epidermal growth factor receptor 2 testing in primary breast cancer in the era of standardized testing: a Canadian prospective study.

C. Gilks, A. Magliocco, S. Nofech-Mozes, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of PALB2/FANCN-associated breast cancer families

Petra M. Nederlof, Jorge S. Reis-Filho, David M. Livingston, 2007, Proceedings of the National Academy of Sciences.

Overexpression of Estrogen Receptors in Columnar Cell Change and in Unfolding Breast Lobules

J. Deschênes, G. Tremblay, L. Alpert, 2005, The breast journal.

Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.

C. Gilks, R. Alaghehbandan, E. Torlakovic, 2011, Archives of pathology & laboratory medicine.

Wilms Tumor Gene Product: Sensitive and Contextually Specific Marker of Serous Carcinomas of Ovarian Surface Epithelial Origin

A. Gown, H. Yaziji, H. Hwang, 2004, Applied immunohistochemistry & molecular morphology : AIMM.

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

Marc Tischkowitz, Nancy Hamel, Aditi Soni, 2008, European Journal of Human Genetics.

Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers

W. Miller, M. Basik, S. Hamel, 2010, Breast Cancer Research and Treatment.

HER‐2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

I. Andrulis, J. Knight, F. O'Malley, 2002, Cancer.

Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study

Hanina Hibshoosh, F. O'Malley, I. Bleiweiss, 2006, Modern Pathology.

The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer.

A. Baccarelli, L. Gaboury, M. Basik, 2009, The American journal of pathology.

Reinventing Nuclear Histo-score Utilizing Inherent Morphologic Cutoffs: Blue-brown Color H-score (BBC-HS)

Z. Gatalica, E. Torlakovic, Darryl Yu, 2023, Applied immunohistochemistry & molecular morphology : AIMM.